MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Safety and Effectiveness of Co-careldopa for Motor Recovery in Post-Stroke Patients: A Systematic Review

A. Younas, M. Qadri, R. Noor, T. Khan, M. Anwar, I. Shahid, HA. Azam Raja, A. Munir, M. Shabih, SH. Ali Inam (Lahore, Pakistan)

Meeting: 2025 International Congress

Keywords: Levodopa(L-dopa)

Category: Dystonia (Other)

Objective: To examine the safety and efficacy of co-careldopa for motor recovery in post-stroke patients.

Background: The use of co-careldopa for improving motor function in post- stroke patients remains a topic of interest. While widely used in Parkinson’s disease, its role in stroke rehabilitation remains largely unknown. Hence, we conducted a systematic review to clarify the role of co-careldopa in enhancing motor function in post-stroke patients.

Method: A comprehensive search was conducted on PubMed, Google Scholar, and the Cochrane Library from inception to July 2024.Only randomized controlled trials and clinical trials were included, focusing on post-stroke patients treated with co-careldopa, compared to a placebo. The primary outcome assessed was motor function improvement, assessed using Rivermead Mobility Index (RMI) and Barthel Index. Secondary outcomes including psychological and cognitive impact and adverse events were also noted.

Results: Four studies with 1746 participants were included. Scheidtmann et al found significant motor improvement, while Shamsei et al. reported a 79.1% improvement in motor function. However, Ford et al. showed no significant improvement in walking ability after 12 months. Psychological outcomes showed improved mood and reduced caregiver burden in the co-careldopa group, but no significant impact on cognitive recovery. Co-careldopa was generally well-tolerated, with no significant adverse events compared to placebo.

Conclusion: Co-careldopa shows potential in enhancing motor recovery, particularly in the acute and subacute phases of stroke. However, the evidence for sustained improvements in walking and cognitive recovery remains inconclusive. Despite potential benefits, further research is needed to delineate the patient subgroups most likely to benefit from this intervention.

Table 1. Outcomes for motor function

Table 1. Outcomes for motor function

To cite this abstract in AMA style:

A. Younas, M. Qadri, R. Noor, T. Khan, M. Anwar, I. Shahid, HA. Azam Raja, A. Munir, M. Shabih, SH. Ali Inam. Safety and Effectiveness of Co-careldopa for Motor Recovery in Post-Stroke Patients: A Systematic Review [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/safety-and-effectiveness-of-co-careldopa-for-motor-recovery-in-post-stroke-patients-a-systematic-review/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/safety-and-effectiveness-of-co-careldopa-for-motor-recovery-in-post-stroke-patients-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley